BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

681 related articles for article (PubMed ID: 19208797)

  • 1. Genomic profiles associated with early micrometastasis in lung cancer: relevance of 4q deletion.
    Wrage M; Ruosaari S; Eijk PP; Kaifi JT; Hollmén J; Yekebas EF; Izbicki JR; Brakenhoff RH; Streichert T; Riethdorf S; Glatzel M; Ylstra B; Pantel K; Wikman H
    Clin Cancer Res; 2009 Mar; 15(5):1566-74. PubMed ID: 19208797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LSAMP, a novel candidate tumor suppressor gene in human osteosarcomas, identified by array comparative genomic hybridization.
    Kresse SH; Ohnstad HO; Paulsen EB; Bjerkehagen B; Szuhai K; Serra M; Schaefer KL; Myklebost O; Meza-Zepeda LA
    Genes Chromosomes Cancer; 2009 Aug; 48(8):679-93. PubMed ID: 19441093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Casein kinase II alpha subunit and C1-inhibitor are independent predictors of outcome in patients with squamous cell carcinoma of the lung.
    O-charoenrat P; Rusch V; Talbot SG; Sarkaria I; Viale A; Socci N; Ngai I; Rao P; Singh B
    Clin Cancer Res; 2004 Sep; 10(17):5792-803. PubMed ID: 15355908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic aberrations in squamous cell lung carcinoma related to lymph node or distant metastasis.
    Boelens MC; Kok K; van der Vlies P; van der Vries G; Sietsma H; Timens W; Postma DS; Groen HJ; van den Berg A
    Lung Cancer; 2009 Dec; 66(3):372-8. PubMed ID: 19324446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunocytological detection of bone marrow micrometastasis in operable non-small cell lung cancer.
    Pantel K; Izbicki JR; Angstwurm M; Braun S; Passlick B; Karg O; Thetter O; Riethmüller G
    Cancer Res; 1993 Mar; 53(5):1027-31. PubMed ID: 7679945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic changes and clonality relationship between primary colorectal cancers and their pulmonary metastases--an analysis by comparative genomic hybridization.
    Jiang JK; Chen YJ; Lin CH; Yu IT; Lin JK
    Genes Chromosomes Cancer; 2005 May; 43(1):25-36. PubMed ID: 15723340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic classification of lung adenocarcinoma based on array-based comparative genomic hybridization analysis: its association with clinicopathologic features.
    Shibata T; Uryu S; Kokubu A; Hosoda F; Ohki M; Sakiyama T; Matsuno Y; Tsuchiya R; Kanai Y; Kondo T; Imoto I; Inazawa J; Hirohashi S
    Clin Cancer Res; 2005 Sep; 11(17):6177-85. PubMed ID: 16144918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonrandom DNA copy number changes related to lymph node metastases in squamous cell carcinoma of the lung.
    Rydzanicz M; Giefing M; Ziolkowski A; Kasprzyk M; Gabriel A; Dyszkiewicz W; Szyfter K
    Neoplasma; 2008; 55(6):493-500. PubMed ID: 18999877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of genes involved in squamous cell carcinoma of the lung using synchronized data from DNA copy number and transcript expression profiling analysis.
    Lo KC; Stein LC; Panzarella JA; Cowell JK; Hawthorn L
    Lung Cancer; 2008 Mar; 59(3):315-31. PubMed ID: 18029052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma.
    Lebanony D; Benjamin H; Gilad S; Ezagouri M; Dov A; Ashkenazi K; Gefen N; Izraeli S; Rechavi G; Pass H; Nonaka D; Li J; Spector Y; Rosenfeld N; Chajut A; Cohen D; Aharonov R; Mansukhani M
    J Clin Oncol; 2009 Apr; 27(12):2030-7. PubMed ID: 19273703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous T-cell lymphoma-associated lung cancers show chromosomal aberrations differing from primary lung cancer.
    Hahtola S; Burghart E; Puputti M; Karenko L; Abdel-Rahman WM; Väkevä L; Jeskanen L; Virolainen S; Karvonen J; Salmenkivi K; Kinnula V; Joensuu H; Peltomäki P; Klein CA; Ranki A
    Genes Chromosomes Cancer; 2008 Feb; 47(2):107-17. PubMed ID: 17985357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gain at chromosomal region 5p15.33, containing TERT, is the most frequent genetic event in early stages of non-small cell lung cancer.
    Kang JU; Koo SH; Kwon KC; Park JW; Kim JM
    Cancer Genet Cytogenet; 2008 Apr; 182(1):1-11. PubMed ID: 18328944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative genomic hybridization array analysis and real time PCR reveals genomic alterations in squamous cell carcinomas of the lung.
    Choi YW; Choi JS; Zheng LT; Lim YJ; Yoon HK; Kim YH; Wang YP; Lim Y
    Lung Cancer; 2007 Jan; 55(1):43-51. PubMed ID: 17109992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicolor fluorescence in situ hybridization and comparative genomic hybridization reveal molecular events in lung adenocarcinomas and squamous cell lung carcinomas.
    Shen H; Gao W; Wu YJ; Qiu HR; Shu YQ
    Biomed Pharmacother; 2009 Jul; 63(6):396-403. PubMed ID: 18848758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a novel homozygous deletion region at 6q23.1 in medulloblastomas using high-resolution array comparative genomic hybridization analysis.
    Hui AB; Takano H; Lo KW; Kuo WL; Lam CN; Tong CY; Chang Q; Gray JW; Ng HK
    Clin Cancer Res; 2005 Jul; 11(13):4707-16. PubMed ID: 16000565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integration of DNA copy number alterations and prognostic gene expression signatures in breast cancer patients.
    Horlings HM; Lai C; Nuyten DS; Halfwerk H; Kristel P; van Beers E; Joosse SA; Klijn C; Nederlof PM; Reinders MJ; Wessels LF; van de Vijver MJ
    Clin Cancer Res; 2010 Jan; 16(2):651-63. PubMed ID: 20068109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA gains in 3q occur frequently in squamous cell carcinoma of the lung, but not in adenocarcinoma.
    Björkqvist AM; Husgafvel-Pursiainen K; Anttila S; Karjalainen A; Tammilehto L; Mattson K; Vainio H; Knuutila S
    Genes Chromosomes Cancer; 1998 May; 22(1):79-82. PubMed ID: 9591638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunocytochemical detection of occult tumor cells in the bone marrow: prognostic impact on early stages of lung cancer.
    Nosotti M; Tosi D; Palleschi A; Rosso L; Mendogni P; Santambrogio L
    Eur Surg Res; 2008; 41(3):267-71. PubMed ID: 18594145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of clinical outcome in multiple lung cancer cohorts by integrative genomics: implications for chemotherapy selection.
    Broët P; Camilleri-Broët S; Zhang S; Alifano M; Bangarusamy D; Battistella M; Wu Y; Tuefferd M; Régnard JF; Lim E; Tan P; Miller LD
    Cancer Res; 2009 Feb; 69(3):1055-62. PubMed ID: 19176396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrative genomic analysis of small-cell lung carcinoma reveals correlates of sensitivity to bcl-2 antagonists and uncovers novel chromosomal gains.
    Olejniczak ET; Van Sant C; Anderson MG; Wang G; Tahir SK; Sauter G; Lesniewski R; Semizarov D
    Mol Cancer Res; 2007 Apr; 5(4):331-9. PubMed ID: 17426248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.